Equities research analysts at Deutsche Bank initiated coverage on shares of Colgate-Palmolive (NYSE:CL) in a report issued on Wednesday, The Fly reports. The firm set a “hold” rating on the stock.
Several other brokerages have also commented on CL. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, October 17th. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. SunTrust Banks upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating and upped their price target for the stock from $65.00 to $85.00 in a research note on Wednesday, October 11th. Societe Generale lowered Colgate-Palmolive from a “hold” rating to a “sell” rating and set a $66.00 price target for the company. in a research note on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Royal Bank of Canada restated a “hold” rating and set a $74.00 price target on shares of Colgate-Palmolive in a research note on Sunday, October 8th. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and four have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $76.04.
Shares of Colgate-Palmolive (CL) traded up $0.86 during trading hours on Wednesday, reaching $73.35. The company’s stock had a trading volume of 3,813,048 shares, compared to its average volume of 3,605,857. The firm has a market capitalization of $64,410.00, a price-to-earnings ratio of 25.50, a PEG ratio of 3.35 and a beta of 0.81. The company has a debt-to-equity ratio of 24.42, a current ratio of 1.23 and a quick ratio of 0.92. Colgate-Palmolive has a 12 month low of $63.43 and a 12 month high of $77.27.
In other Colgate-Palmolive news, insider Victoria L. Dolan sold 9,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 14th. The stock was sold at an average price of $73.41, for a total transaction of $660,690.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, November 9th. The shares were sold at an average price of $73.07, for a total value of $730,700.00. Following the sale, the insider now owns 60,528 shares of the company’s stock, valued at approximately $4,422,780.96. The disclosure for this sale can be found here. In the last quarter, insiders sold 173,673 shares of company stock valued at $12,629,293. Insiders own 1.02% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the business. Transamerica Financial Advisors Inc. lifted its holdings in Colgate-Palmolive by 0.3% during the 1st quarter. Transamerica Financial Advisors Inc. now owns 25,183 shares of the company’s stock worth $1,844,000 after buying an additional 67 shares during the last quarter. Ronald Blue & Co. LLC lifted its holdings in Colgate-Palmolive by 1.1% during the 1st quarter. Ronald Blue & Co. LLC now owns 3,501 shares of the company’s stock worth $256,000 after buying an additional 37 shares during the last quarter. USS Investment Management Ltd lifted its holdings in Colgate-Palmolive by 1.6% during the 1st quarter. USS Investment Management Ltd now owns 683,600 shares of the company’s stock worth $50,036,000 after buying an additional 10,600 shares during the last quarter. Stifel Financial Corp lifted its holdings in Colgate-Palmolive by 0.8% during the 1st quarter. Stifel Financial Corp now owns 303,934 shares of the company’s stock worth $22,250,000 after buying an additional 2,360 shares during the last quarter. Finally, ARS Investment Partners LLC lifted its holdings in Colgate-Palmolive by 0.5% during the 1st quarter. ARS Investment Partners LLC now owns 35,531 shares of the company’s stock worth $2,601,000 after buying an additional 175 shares during the last quarter. Hedge funds and other institutional investors own 72.96% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Deutsche Bank Begins Coverage on Colgate-Palmolive (CL)” was posted by American Banking and Market News and is the sole property of of American Banking and Market News. If you are reading this piece of content on another site, it was stolen and reposted in violation of United States and international copyright & trademark law. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/12/13/deutsche-bank-begins-coverage-on-colgate-palmolive-cl.html.
About Colgate-Palmolive
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
